Show Notes
In this episode, we take a deep dive into Methylene Blue, a compound with a fascinating history as the world's first fully synthetic therapeutic agent. We explore its journey from a 19th-century textile dye to its modern-day popularity in the biohacking community as a potential nootropic and anti-aging supplement. Join us as we break down the complex science, its single FDA-approved use for methemoglobinemia, and the critical risks that are often overlooked in the social media hype
CHAPTERS: 00:00 - Intro 00:15 - What is Methylene Blue? 01:06 - The History of Methylene Blue: From Dye to Drug 03:59 - How it Works: Pleiotropic Effects & Hormesis 05:02 - Mechanism 1: Enhancing Mitochondrial Function 08:50 - Mechanism 2: Neuromodulation & MAO-A Inhibition 10:58 - Mechanism 3: Use as a Vasopressor 12:22 - Mechanism 4: Its ONLY FDA-Approved Use (Methemoglobinemia) 14:41 - Clinical Applications: Rescue Agent vs. Remodeling Agent 17:05 - Potential Use in Neurodegenerative Diseases 19:10 - Other Potential Uses: Psychiatry, Malaria & More 20:51 - The Rise of Methylene Blue as a "Biohack"
SELECTED REFERENCES https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2015.00179/full https://pmc.ncbi.nlm.nih.gov/articles/PMC6485827/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5826781/ https://pubmed.ncbi.nlm.nih.gov/36180986/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2078225/
*Disclaimer* This video is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition.
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.